Signal transduction and oncogenesis by ErbB/HER receptors.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D019281:Dimerization; D015536:Down-Regulation; D004789:Enzyme Activation; D008024:Ligands; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy / Q000209:etiology; D011493:Protein Kinase C / Q000378:metabolism; D017346:Protein Serine-Threonine Kinases; D011505:Protein-Tyrosine Kinases / Q000378:metabolism*; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D013329:Structure-Activity Relationship; D010738:Type C Phospholipases / Q000378:metabolism
D000911:Antibodies, Monoclonal; D008024:Ligands; D020928:Mitogen-Activated Protein Kinases; D011493:Protein Kinase C; D017346:Protein Serine-Threonine Kinases; D011505:Protein-Tyrosine Kinases; D011518:Proto-Oncogene Proteins; D051057:Proto-Oncogene Proteins c-akt; D018719:Erb-b2 Receptor Tyrosine Kinases; D010738:Type C Phospholipases; C432456:phospholipase C1